Matches in Wikidata for { <http://www.wikidata.org/entity/Q89154647> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q89154647 description "clinical trial" @default.
- Q89154647 description "ensayu clínicu" @default.
- Q89154647 description "klinisch onderzoek" @default.
- Q89154647 description "клінічне випробування" @default.
- Q89154647 name "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 name "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 name "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 type Item @default.
- Q89154647 label "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 label "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 label "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 prefLabel "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 prefLabel "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 prefLabel "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection" @default.
- Q89154647 P1050 Q89154647-6E9E7755-F8DD-41BC-93C1-1C5C19A94EB1 @default.
- Q89154647 P1132 Q89154647-52E1D574-1C06-4768-8A89-A73AA4D38AFE @default.
- Q89154647 P1476 Q89154647-C713EAF1-C38B-4D41-9E19-C5C572D988C2 @default.
- Q89154647 P17 Q89154647-CF704553-F5A3-4986-9539-DB3BF616FCD5 @default.
- Q89154647 P1813 Q89154647-CF98CC97-7AD5-4650-A6F9-598AAFE1D0EC @default.
- Q89154647 P2899 Q89154647-55579D8F-013C-460C-B5A4-E7018320DBF7 @default.
- Q89154647 P3098 Q89154647-3E8C000B-55A5-43AF-A52A-0192DB7F1AF3 @default.
- Q89154647 P31 Q89154647-05ED1757-330D-4105-A402-129047E797D4 @default.
- Q89154647 P4844 Q89154647-451CCEB5-7864-4253-BF39-78C725362AF7 @default.
- Q89154647 P580 Q89154647-A3160696-21DC-4375-B2A2-C5A581B8333F @default.
- Q89154647 P582 Q89154647-AD4D8F84-D6C2-4E01-8C06-9C0E0A58DA8C @default.
- Q89154647 P8363 Q89154647-C8814E2E-4250-477D-A0E9-2C504AE3A197 @default.
- Q89154647 P921 Q89154647-CE46D231-FD8F-4AFB-883C-31F1FF937DC6 @default.
- Q89154647 P1050 Q103177 @default.
- Q89154647 P1132 "+50" @default.
- Q89154647 P1476 "An Observational Case-control Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications" @default.
- Q89154647 P17 Q38 @default.
- Q89154647 P1813 "SISCO" @default.
- Q89154647 P2899 "+18" @default.
- Q89154647 P3098 "NCT04322188" @default.
- Q89154647 P31 Q30612 @default.
- Q89154647 P4844 Q3960572 @default.
- Q89154647 P580 "2020-03-19T00:00:00Z" @default.
- Q89154647 P582 "2020-05-19T00:00:00Z" @default.
- Q89154647 P8363 Q818574 @default.
- Q89154647 P921 Q84263196 @default.